Intrepid Labs Funding, Investors & Competitors

Astromech is an artificial intelligence company spun out of Colossal Biosciences, founded by Ben Lamm. It uses AI to analyze biological data and forecast evolution and disease risk, applying its platform to biotech research.

Chai Discovery is a San Francisco-based applied AI research lab, founded in 2024, that builds foundation models to predict and design interactions between biochemical molecules for drug discovery. Its models, including Chai-1, Chai-2, and Chai-3, are used to design molecules such as antibodies for difficult drug targets, with its most recent model achieving a de novo antibody hit rate far above prior computational methods. The company's technology has been used by pharmaceutical partners including Eli Lilly, Pfizer, and Novartis.

Pathos is an AI drug development company leveraging multimodal data for therapy discovery. Based in Boston, Massachusetts, it combines machine learning with clinical expertise to advance oncology and immunology pipelines. Pathos has raised over $100 million in funding and partners with pharmaceutical firms on target identification. Founded in 2022, it operates across preclinical and clinical stages.

InSilico Medicine Cayman TopCo is engaged in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms. It has generated multiple clinical-stage or IND-enabling assets using Pharma.AI, an AI-enabled platform that supports drug discovery and development activities. The company operates under a project-based business model, deriving revenue from out-licensing and collaboration arrangements. Geographically, the company generates revenue from multiple countries, with the majority of the revenue coming from United States.

Anthropic is an AI safety company developing large language models and researching methods to make artificial intelligence more reliable and steerable. Anthropic was founded in 2021 by former OpenAI researchers including Dario and Daniela Amodei. The company's flagship product is Claude, a family of AI assistants deployed across consumer applications and enterprise APIs. Research priorities center on constitutional AI, mechanistic interpretability, and alignment techniques. Major investors include Google, Spark Capital, and Salesforce Ventures.

OpenAI is an AI research and deployment company that develops large language models, including the GPT series, and consumer-facing products such as ChatGPT. Founded in 2015 as a nonprofit research lab, the organization transitioned to a capped-profit structure in 2019 to attract the capital needed for large-scale AI development. The company offers API access to its models for enterprise and developer use, alongside image generation through DALL-E and code-assistance tools. Headquartered in San Francisco, OpenAI has become one of the most prominent players in the generative AI space, backed by a multibillion-dollar investments from Microsoft, Amazon, NVIDIA, SoftBank and many more.

Founded in 2012, Snowflake is a fully managed platform that consolidates data hosted on different public clouds for centralized analytics and governance. Snowflake’s cloud-native architecture allows users to independently scale the compute and storage layers, providing customers with optimized performance at lower costs. The company’s data lake and data warehouse products support a variety of use cases, including business analytics, data engineering, and artificial intelligence. Snowflake is widely used by Fortune 2000 companies in financial services, media, and retail sectors.

DeepSeek is a Chinese frontier AI lab that develops open-source large language models. DeepSeek conducts research in machine learning, natural language processing and related AI applications. DeepSeek has earned global recognition by challenging the hegemony of U.S. AI incumbents (like OpenAI and Google) through technological breakthroughs in efficiency and reasoning. DeepSeek-R1: A powerful reasoning model that rivals premium Western models. Its unique capability to mimic human thought and break down mathematical or programming tasks incrementally sent shockwaves through the tech industry.DeepSeek-V3 & V4: State-of-the-art general language models capable of running incredibly fast while consuming significantly less computational power than peer models.

Merck KGaA operates in three main segments: life science, electronics, and healthcare. The life science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Cognition is a San Francisco-based applied AI lab developing end-to-end software agents that function as collaborative teammates for engineering projects. Its agents automate complex tasks to boost team efficiency and innovation through https://www.cognition.ai.

Project Prometheus is an artificial intelligence company developing AI systems for the physical economy, with applications across engineering and manufacturing in sectors such as aerospace, automotive, and computing. Founded in 2025 and headquartered in San Francisco with offices in London and Zurich, the company is co-led by Amazon founder Jeff Bezos and Vik Bajaj, a chemist and physicist formerly of Google X and co-founder of Verily. Unlike large language models that learn primarily from digital text, Prometheus focuses on AI that learns from real-world experimentation and physical trial and error, aiming to optimize design, production, and performance in industrial settings. The company launched with $6.2 billion in initial funding and subsequently closed a $10 billion round at a valuation of approximately $38 billion, with participation from investors including JPMorgan Chase and BlackRock. Its team has grown to over 120 employees, drawing talent from OpenAI, Google DeepMind, and Meta, and the company acquired agentic AI startup General Agents in 2025.

Cohere is a Canadian artificial intelligence company headquartered in Toronto that builds large language models and enterprise AI products for regulated industries. It was founded in 2019 by Aidan Gomez, Ivan Zhang and Nick Frosst. Its products include the Command family of generative models, Embed and Rerank retrieval models, and the North platform for business use, which can run in private clouds, on premises or in isolated virtual private clouds. Customers come mainly from finance, healthcare, manufacturing, energy and the public sector. The company has offices in Toronto, Montreal, New York, San Francisco, London, Paris and Seoul. It raised a US$500 million round at a US$6.8 billion valuation in August 2025 and extended it by US$100 million in September 2025. Cohere bought the Vancouver start-up Cognosys in May 2025 and the biopharma AI company Reliant AI in May 2026.

Moonshot AI is a Beijing-based foundation-model company best known for the Kimi family of long-context and multimodal artificial-intelligence assistants. The company develops proprietary large language models, consumer chat products, application-programming interfaces and tools for reasoning over long documents. Its offerings address consumers, software developers and enterprises that use generative AI for research, content, coding and knowledge work. Moonshot monetizes through model access, application subscriptions and usage-based API services while investing heavily in model training and inference infrastructure. Kimi became one of China’s most visible independent AI assistants as the company competed on context length, reasoning and multimodal capabilities. HKIC’s 2025 annual report places Moonshot among its selected AI portfolio companies and dates the investment on its official portfolio timeline.

Illumina is a genomics company headquartered in San Diego, California, that develops and sells DNA sequencing and array-based systems for research, clinical and applied markets. It was incorporated in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik and Mark Chee, and its shares trade on the Nasdaq under the symbol ILMN. Its NovaSeq, NextSeq and MiSeq sequencers and microarrays are bought by genomic research centers, pharmaceutical companies, academic institutions and clinical laboratories. Revenue comes from instrument sales and from the consumables and services used with an installed base of about 21,000 systems in 165 countries. Fiscal 2025 revenue was $4.34 billion, flat on 2024, with GAAP net income of $850 million, and the company has about 8,600 employees. It acquired the cancer-detection company GRAIL in 2021 and completed its spin-off in June 2024, keeping a 14.5% minority stake. In January 2025 it invested $20 million in Truveta alongside Regeneron to support the Truveta Genome Project.

Safe Superintelligence is a Palo Alto-based AI firm building systems with embedded safety protocols. Launched in 2024, the company develops risk assessment frameworks and mitigation tools to ensure secure deployment of advanced models in enterprise settings.

Z.ai is an advanced artificial intelligence platform known for its GLM model series, multimodal creation tools, and cost-efficient agentic coding environments like ZCode. It provides high-performance reasoning, real-time web search capabilities, and versatile utilities for building full-stack applications and data dashboards.

Reflection AI is a Brooklyn, New York-based artificial intelligence company that develops open-weight frontier foundation models and autonomous software agents. It was founded in 2024 by former Google DeepMind researchers Misha Laskin and Ioannis Antonoglou, and its first product, Asimov, is a code-research agent that helps engineering teams understand and work across large codebases. The company has since repositioned around open frontier models and end-to-end AI systems sold to governments, large enterprises and public sector institutions that want full control over their AI stack. Reflection emerged from stealth in March 2025 with $130 million across a $25 million seed round led by Sequoia Capital and CRV and a $105 million Series A led by Lightspeed Venture Partners and CRV. It raised $2 billion at an $8 billion valuation in October 2025 in a round led by Nvidia, and in April 2026 closed a $2.5 billion Series C at a $25 billion pre-money valuation. In June 2026 it signed a compute agreement with SpaceX worth up to $6.3 billion, and it had about 320 employees in 2026.

Mistral AI is a Paris-headquartered developer of open-source large language models outperforming GPT-3.5 benchmarks. The company releases models like Mistral 7B, Mixtral 8x7B with 46.7 percent MT-Bench scores, and Pixtral 12B for vision-language tasks. Enterprises deploy these via La Plateforme API supporting 80 billion parameter models for coding, translation, and summarization. Mistral AI partners with Microsoft Azure and NVIDIA for inference hardware. Founded in 2023, it serves clients in automotive and finance across Europe and the U.S.